Chenggang Li from Maineville, OH, age 44

view source

Treatment Of Lymphangioleiomyomatosis
view source
US Patent:

20160022706, Jan 28, 2016
Filed:

Mar 4, 2014
Appl. No.:

14/771817
Inventors:

- Boston MA, US
Chenggang LI - Maineville OH, US
Assignee:

THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
International Classification:

A61K 31/616
A61K 31/192
A61K 31/436
A61K 31/18
A61K 45/06
Abstract:

Embodiments disclosed herein provide compositions and methods for treating lymphangioleiomyomatosis (LAM) comprising inhibiting COX overexpression and prostaglandin over production by administering at least one COX inhibitor and/or prostaglandin biosynthetic pathway inhibitors. Lymphangioleiomyomatosis (LAM) is a rare lung disease. Some LAM occurances are associated with mutations in the tuberous sclerosis complex (TSC) locus. LAM occurs almost exclusively in women, usually of childbearing age.

Chenggang Li